Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

News feed

Promomed and Vinafarm have agreed on strategic cooperation

9/12/25 PRMD

Rostelecom acquired a controlling stake in ASTOR

9/12/25 RTKM

MGKL's revenue in January–August increased 3.3 times

9/12/25 MGKL

M.Video-Eldorado has opened the first brand zone Made in Belarus

9/11/25 MVID

Fesco gained control over part of the assets of PCMTP

9/11/25 FESH

Aeroflot passenger traffic in August decreased by 1.7%

9/11/25 AFLT

VTB has found a buyer for Rosgosstrakh

9/11/25 VTBR

VTB has found a buyer for Rosgosstrakh

9/11/25 RGSS

Astra will purchase servers for the cloud platform for ₽1 billion

9/11/25 ASTR

Yandex.Lavka has launched a new format with an expanded assortment

9/10/25 YDEX